US Market Access Strategy Consulting Patient interests alone are not reshaping the GLP-1 market
BPC-157 is a synthetic peptide based on a sequence found in a protective protein in the stomach
Learn more about her work
This unique formula provides triple glutathione protection, specifically engineered to support healthy lungs, skin, eyes, and a robust immune system
Exclusivity Upon NDA approval of a new chemical entity, or NCE, which is a drug that contains no active moiety that has been approved by FDA in any other NDA, that drug receives five years of exclusivity during which FDA may not receive any ANDA seeking approval of a generic version of that drug
As a result, the product format provides long-term stability for laboratory research purposes